A Human Genetics Framework for De-risking Gene Editing Targets for Hematopoietic Cell and Gene Therapy
Abhinav Dhall, Alyssa Pyclik, Matthew H. Ung…·John R. Lydeard
The paper develops a proteogenomic framework to identify dispensable genes for safer gene editing in hematopoietic therapies, identifying 237 candidates including LY75.